Virtus ETF Advisers’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-155,009
| Closed | -$527K | – | 420 |
|
|
2018
Q3 | $527K | Buy |
155,009
+10,445
| +7% | +$35.5K | 0.05% | 115 |
|
|
2018
Q2 | $544K | Sell |
144,564
-54,525
| -27% | -$205K | 0.48% | 135 |
|
|
2018
Q1 | $814K | Sell |
199,089
-11,577
| -5% | -$47.3K | 0.71% | 70 |
|
|
2017
Q4 | $980K | Buy |
210,666
+53,601
| +34% | +$249K | 1.23% | 25 |
|
|
2017
Q3 | $1.12M | Hold |
157,065
| – | – | 0.15% | 54 |
|
|
2017
Q2 | $1.14M | Sell |
157,065
-26,842
| -15% | -$194K | 0.17% | 41 |
|
|
2017
Q1 | $1.13M | Buy |
183,907
+17,684
| +11% | +$109K | 0.2% | 55 |
|
|
2016
Q4 | $974K | Buy |
166,223
+60,346
| +57% | +$354K | 0.29% | 54 |
|
|
2016
Q3 | $562K | Buy |
105,877
+13,341
| +14% | +$70.8K | 0.27% | 65 |
|
|
2016
Q2 | $613K | Sell |
92,536
-43,936
| -32% | -$291K | 0.45% | 27 |
|
|
2016
Q1 | $637K | Hold |
136,472
| – | – | 0.88% | 24 |
|
|
2015
Q4 | $689K | Buy |
+136,472
| New | +$689K | 1.89% | 6 |
|